Could Low Float (Nasdaq: ARTL) Become A Market Standout This Monday?

April 13th

Greetings, Friend!

My complete attention Monday will be on Artelo Biosciences, Inc. (Nasdaq: ARTL).

Artelo Biosciences, Inc. is a clinical stage pharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that modulate lipid-signaling pathways including the endocannabinoid system.

Artelo is advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, anxiety, pain, neuropathy, and inflammation.

Here’s why it’s highly notable right now...

This situation involves a low float. With approximately 3.25Mn shares available and circulating, the possibility of sharp chart shifts may be high.

The small number of available shares in ARTL's float might explain its ability to jump from $1.185 on February 5th, 2025, to $1.5495 the following day.

That’s a surge of over 30% almost instantly!

While outcomes are never certain, having around 3.25Mn shares in its float could increase the likelihood of pronounced chart swings for ARTL.

More details on (Nasdaq: ARTL) will follow. Think about it for your watchlist!

All the best,

Dane James

Editor Market Pulse Today

(Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.)